Pharmacist, Jungmee Park
CellMed 2023; 13(13): 3.1-3.5Objective: A case study on improvement of alopecia through OCNT.
Methods: 62-year-old woman suffering from alopecia symptoms and thinning hair due to stress and overwork after her marriage.
Results: Hair got thicker following the implementation of nutrition therapy with improvement of alopecia symptoms at the crown and lateral aspects of the head.
Conclusion: Nutrition therapy can be helpful in promoting hair growth and increase in hair thickness for patients displaying alopecia symptoms.
Pharmacist, Neung su Cheon
CellMed 2023; 13(13): 4.1-4.5Objective: A Case report on the improvement of infertility through implementation of OCNT.
Methods: Korea woman in her 40’s failed in all of her attempts to have a second child.
Results: Pregnancy of the second child was confirmed following the implementation of nutrition therapy.
Conclusion: Application of nutrition therapy to infertile patient can be helpful for pregnancy.
Pharmacist, Sunhee Kang
CellMed 2023; 13(13): 5.1-5.4Objective: Case report of hypothyroidism improved by ortho-cellular nutrition therapy.
Methods: A 55-year-old Korean woman diagnosed with hypothyroidism in the past, did not take any Synthyroid medication while undergoing OCNT for a year.
Results: A blood test was conducted one year after the initiation of OCNT, and she was diagnosed with normal thyroid hormone level.
Conclusion: Applying nutritional therapy to patients with hypothyroidism may assist in the recovery of thyroid hormone levels and the alleviation of symptoms.
Pharmacist, Sunhee Kang
CellMed 2023; 13(12): 1.1-1.8Objective: A case report of pain relief and fracture recovery by ortho-cellular nutrition therapy in a patient with 2nd, 3rd, and 4th metatarsal fractures (closed).
Methods: A Korean woman in her 50s was diagnosed with 2nd, 3rd, and 4th metatarsal fractures (closed) with severe initial pain and fractures. Surgery was recommended but could not be performed immediately due to her situations at work.
Results: With OCNT performed immediately after the fracture, the pain completely disappeared, and even during subsequent recovery, recovery was faster than in other fracture cases.
Conclusion: OCNT may help patients with similar problems relieve symptoms and recover.
Pharmacist, Sun L Riehm
CellMed 2023; 13(12): 2.1-2.7Objective: A case of reducing adverse effects associated with imatinib using Cyaplex F.
Methods: The 52 year old female with past medical history of stage 1 triple positive breast cancer 10 years ago and current metastatic melanoma has been complaining adverse effects after imatinib was started.
Results: After OCNT was initiated, the patient’s headache and muscle pain have been much tolerable and her AST/CPK levels were returned close to her baseline.
Conclusion: OCNT may reduce side effects caused by Imatinib and help patient to stay with the current chemotherapy regimen.
Pharmacist, Hye-Ran Park
CellMed 2023; 13(12): 3.1-3.5Pharmacist, Hae yeon Hwang
CellMed 2023; 13(12): 4.1-4.7Objective: Report cases of improvement in pancreatic cancer through Ortho-Cellular Nutrition Therapy.
Methods: Korean males in their 70 ’s were suffering from pancreatic cancer following full recovery from prostate cancer.
Results: There was the improvement in pancreatic cancer follow ing implementation of OCNT.
Conclusion: Application of OCNT to pancreatic cancer can be helpful in alleviating symptoms.
Pharmacist, Myung Jin Cha
CellMed 2023; 13(12): 5.1-5.8Objective: A case report on the improvement of symptoms in an osteoporosis patient using ortho-cellular nutrition therapy.
Methods: Currently a 70 years old Korean woman was diagnosed with osteoporosis in her late 50s around 2010 and continued to receive injection treatments once every three months. Her T-score did not improve, and fractures continued to occur in the ankles, wrists, shoulders, ribs, etc., even from light impacts.
Results: The patient underwent an osteoporosis test in February 2019, which resulted in an average T-score of -2.5 or less, equivalent to being diagnosed with osteoporosis. OCNT has been performed since May 2019 (late 60s), and in the test received in April 2020, the T-score value improved to over -2.5 and was determined normal at the hospital. Since then, OCNT continued without any further injection treatments. Unlike before, even when she fell hard, she only suffered bruises without fractures, and no additional fractures have occurred.
Conclusion: OCNT may help patients with similar problems relieve symptoms and recover.
Pharmacist, Jeonghwa Baek
CellMed 2023; 13(11): 1.1-1.9Objective: A case report on the Leukopenia Patients Using Ortho Cellular Nutrition Therapy (OCNT)
Methods: A Korean female in her 50s suffering from the rare side effect of leukopenia after taking athlete's foot medicine (Terbinafine HCl)
Results: The results revealed that the white blood cell count, which had dropped before the OCNT, had improved to a normal level.
Conclusion: The application of the OCNT can help change health related figures in patients with relevant problems.
Pharmacist, Yeon Choi
CellMed 2023; 13(11): 2.1-2.3Objective: A case report on the improvement of rheumatoid arthritis using Ortho-Cellular Nutrition Therapy (OCNT)
Methods: A Korean woman in her 50s is suffering from rheumatoid arthritis.
Results: Rheumatoid arthritis improved after performing OCNT.
Conclusion: OCNT can be helpful in the treatment of patients with rheumatoid arthritis.
Bong-Keun Jang, Sunyoung Park, Dahyun Mun, Gunwoo Lee, Youngsun Kwon, Hye-yeon Kang, Jeom-Yong Kim
CellMed 2023;13: 4.1-4.6Pharmacist, Min-soo Son
CellMed 2023;13: 2.1-2.3042-716-7299